Pharmaceutical industry – Page 53
-
Opinion
New antibiotics: what's the hold up?
It’s more a research problem, than a commercial one, says Derek Lowe
-
Business
Alcohol dependence pill approved in EU
Selincro tablets from Lundbeck designed to reduce consumption of alcohol
-
Business
UK considers patent rule change for trials
Government to change law that organisations say makes the country less appealing as a location for clinical trials
-
Business
Talk of a $6.6bn deal for Elan
Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights
-
Business
$595m octreotide deal grabs Roche
Company will get worldwide rights to oral formulation of growth hormone drug
-
Business
Merck resolves Vytorin case for $688m
Investors say the company knew about Enhance trial failure but withheld information
-
Business
BMS sells OTC drugs for $482m
Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser
-
Business
Biogen buys Tysabri from Elan for $3.25bn
Elan earns huge cash injection for blockbuster drug
-
Business
GSK commits to AllTrials data disclosure
Company will begin publishing all clinical study reports
-
Business
Zoetis IPO launches at $2.2bn
Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
-
Opinion
Name reactions: how does the label stick?
Derek Lowe investigates the long running tradition of naming reactions after their inventors
-
Business
Allergan buys MAP for $958m
Deal strengthens Allergan’s position in neurology with Levadex for treating migraine
-
Business
Vasella to leave Novartis in August
Long serving chair of the board of directors will be succeeded by Jörg Reinhardt
-
Business
Flu vaccine without the eggs approved
Flublok does not require flu virus or eggs for manufacture
-
Business
India pushes for emergency drug licences
Government looks set to force licensing of three patented cancer drugs
-
Business
Laropiprant recalled
Merck & Co says it is recalling Tredaptive tablets, approved in the EU for treating patients with high cholesterol
-
Business
Pharma industry 'strategic crisis'
The problem is shrinking margins, caused by price and cost pressure, regulatory change and expiring patents, report says
-
Business
Wellcome Trust launches investment wing
Trust provides £200 million to create Syncona, which will support innovative healthcare businesses
-
Business
TB drug milestone for bedaquiline
First TB drug with a new mechanism of action for 40 years wins approval